Bluejay Diagnostics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Bluejay Diagnostics, Inc. (BJDX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-12
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $183.00, a 96.18% decline year-over-year.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was -$1.56K, a 126.01% decline year-over-year.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $1.31K, a 88.95% decline year-over-year.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $4.79K.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $6.00, a 99.97% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $20.09K, a 17.60% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $24.39K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-12-31 | $6.00 10-K · filed 2026-03-06 | |||
| 2025-09-30 | $183.00 10-Q · filed 2025-11-07 | -$1.38K derived: sum of 2 quarters · filed 2026-08-12 | -$68.00 derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$1.56K 10-Q · filed 2026-08-12 | -$251.00 derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $1.31K 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | $20.09K 10-K · filed 2026-03-06 | |||
| 2024-09-30 | $4.79K 10-Q · filed 2025-11-07 | $10.80K derived: sum of 2 quarters · filed 2025-11-07 | $22.68K derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $6.01K 10-Q · filed 2025-11-07 | $17.88K derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $11.87K 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $24.39K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$42.48K 10-Q · filed 2023-11-09 | -$14.78K derived: sum of 2 quarters · filed 2023-11-09 | $39.95K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2023-06-30 | $27.70K 10-Q · filed 2023-11-09 | $82.43K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2023-03-31 | $54.73K 10-Q · filed 2023-11-09 | |||
| 2022-09-30 | $113.22K 10-Q · filed 2023-11-09 | $219.33K derived: sum of 2 quarters · filed 2023-11-09 | $345.42K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $106.11K 10-Q · filed 2023-11-09 | $232.20K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $126.09K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |